Email Updates

You are here

Home

26 MARCH 2021 VOLUME 23 ISSUE 12

Media Coverage

  • Why South Africa’s HIV Prevention Programmes Should Include Sex Worker Clients

    There are around 150,000 sex workers in South Africa. The National Strategic Plan on HIV identifies sex workers as a “key population” at high risk of HIV. HIV prevalence for female sex workers ranged from 48 percent to 72 percent in 2013/2014. This was much higher than for adult women in the general population, where prevalence was 14.4 percent. Reducing the prevalence of HIV among sex workers is prioritised as a critical national-level response to HIV.

    March 25, 2021
    General
    The Conversation

  • More Young Zambians Are Testing for HIV Than Ever Before

    An analysis of HIV testing among young people (ages 15-24) in Zambia in the last decade suggests 65 percent of young women and 49 percent of young men are taking yearly tests.

    March 25, 2021
    General, Voluntary Medical Male Circumcision
    Avert

  • UNAIDS Adopts New Global AIDS Strategy

    UNAIDS, the Joint United Nations (UN) Program on HIV (human immunodeficiency virus) and AIDS (acquired immune deficiency syndrome), said on Thursday that it had adopted a new global strategy to end AIDS as a public health threat by 2030.

    March 25, 2021
    General
    Xinhua

  • Opinion: What Is the Way Forward for PEPFAR Amid COVID-19?

    President Joe Biden’s administration has made early progress on returning the United States to global health engagement. Biden reaffirmed the US commitment to the World Health Organization on Jan. 21 — the first full day of his presidency. Now, the US must consider the incredible equities that exist from decades of fighting HIV and AIDS.

    March 25, 2021
    General
    Devex

  • Black Women Should Get to Decide Whether PrEP Is an Option

    Pre-exposure prophylaxis, also known as PrEP, is the preventative medication used to reduce the spread of HIV/AIDS. It’s been available to people for almost a decade. But not everyone knows about it. Many people in the Black community, specifically Black women, either aren’t aware of PrEP or aren’t thoroughly educated on it. Therefore, many Black women aren’t taking advantage of its benefits as it pertains to HIV/AIDS prevention.

    March 24, 2021
    PrEP
    The Body

  • No ‘4th 90’ — Why Living Well Is Not a Goal When It Comes to HIV

    UNAIDS’ last global strategy for fighting the epidemic, adopted in 2015, set ambitious targets, known as 90-90-90. The goal: By 2020, 90 percent of people living with HIV will know their status; 90 percent of those will be on treatment; and 90 percent of that group will be virally suppressed. The “4th 90” would add another goal: that 90 percent of those with viral suppression would have a good health-related quality of life.

    March 23, 2021
    General
    Politico

  • Doctor Silent About HIV and PrEP? Here’s How Black Women Can Self-Advocate

    In the United States, Black women are four times more likely to die in childbirth than white women and much more likely to have late cancer diagnoses than women of other races. While hospitalized, they are less likely to receive medications to ease acute pain, and at only 13 percent of the US population of women, Black women account for 58 percent of new HIV cases among women.

    March 23, 2021
    PrEP
    The Body

  • Antiretrovirals for HIV Don’t Raise Birth Defect Risk

    The risk for birth defects among infants born to HIV-positive women using antiretroviral therapy is the same as those born to women in the US general population, according to a 30-year review presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2021.

    March 23, 2021
    Treatment
    POZ

  • TB Treatments Are Notoriously Hard To Stick To: Shorter Regimens Offer a Breakthrough

    Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with TB and close to 1.4 million people died. Most (95 percent) of the cases are in low- and middle-income countries.

    March 22, 2021
    General
    The Conversation

  • Top 5 Stories on Injectable HIV Treatment and Prevention From CROI 2021

    One of the most important HIV conferences of the year, the Conference on Retroviruses and Opportunistic Infections (CROI 2021) took place earlier this month. A key theme was the development of injectable medications for use as HIV treatment or as pre-exposure prophylaxis (PrEP). One expert said that the next decade promises to be an era of long-acting medications.

    March 22, 2021
    PrEP, Treatment
    aidsmap

  • Eighty-One Million Condoms Distributed in Zimbabwe Last Year

    A staggering 81 million condoms were distributed in Zimbabwe last year as the country strives to achieve global HIV testing and condom use targets by 2030.

    March 22, 2021
    Male and Female Condoms
    The Chronicle

  • Long-Acting HIV Treatment and PrEP Pipeline Update: So Many Formulations!

    With the recent US Food and Drug Administration (FDA) approval of injectable cabotegravir/rilpivirine (CAB/RPV, Cabenuva), the first long-acting antiretroviral regimen is now available, letting people living with HIV (PLWH) opt for a safe and effective monthly shot instead of daily oral pills. But as game-changing as CAB/RPV is, it’s only the beginning.

    March 22, 2021
    PrEP, Treatment
    The BodyPro

Published Research

Announcements